CoChat

Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing

Open access
Rubin, Jenny, Mansoori, Sharmineh, Blom, Kristin, Berglund, Malin, Lenhammar, Lena, Andersson, Claes, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf · 2018 · Oncotarget
Cited by 19

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

// Jenny Rubin 1 , Sharmineh Mansoori 1 , Kristin Blom 1 , Malin Berglund 1 , Lena Lenhammar 1 , Claes Andersson 1 , Angelica Loskog 2 , Mårten Fryknäs 1 , Peter Nygren 2 and Rolf Larsson 1 1 Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, SE-75185, Sweden 2 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SE-75185, Sweden Correspondence to: Rolf Larsson, email: rolf.larsson@medsci.uu.se Keywords: mebendazole; immune activation; drug repositioning; cancer Received: May 07, 2018 Accepted: June 13, 2018 Published: July 20, 2018 ABSTRACT Mebendazole (MBZ) was recently shown to induce a tumor suppressive M1 phenotype in THP-1 monocytes and macrophages. In the present study the immune effects of MBZ was further investigated using human peripheral blood mononuclear cells (PBMCs) co-cultured with tumour cells. The Biomap platform was used to screen for biomarkers induced from MBZ exposed co-cultures of T-cell receptor activated PBMCs, HT29 colon cancer cells and either human fibroblasts or human umbilical vein endothelial cells (HUVEC) cells. In these co-culture systems MBZ at 0.3-10 μM induced significant increases in TNFα and IFNγ indicating immune stimulation. PBMC cultures alone were subsequently tested for activation status and only in PBMCs activated by CD3/IL2 stimulation and MBZ, at a clinically achievable concentration, was able to increase PBMC clustering and release of pro-inflammatory IFNγ, TNFα, IL6 and IL1β cytokines. Moreover, when PBMC cultures were functionally tested for immune cell killing of lung cancer A549NucLightRed cells, MBZ significantly increased tumour cell apoptosis and reduced the number of surviving tumour cells. This effect was dependent on the presence of CD14 monocytes/macrophages in the co-culture. In summary, MBZ potentiated the immune stimulatory and anticancer effects of anti-CD3/IL2 activated PBMCs which could be relevant to explain the anticancer activity of MBZ observed in the clinic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.25713

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 19

Metadata

Authors
Rubin, J., Mansoori, S., Blom, K., Berglund, M., Lenhammar, L., Andersson, C., Loskog, A., Fryknäs, M., Nygren, P., & Larsson, R.
Venue
Oncotarget
Published
2018-07-20
Volume
9
Issue
56
Pages
30805-30813
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2884122768
Cited by
19
References
8
FWCI
0.87
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.